Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -14.80%6.77B | -6.55%4.6B | 9.80%2.11B | -6.60%12.69B | -19.59%7.95B | -19.16%4.92B | -20.78%1.93B | 13.39%13.59B | 14.79%9.89B | 18.03%6.09B |
| Refunds of taxes and levies | -55.68%3.51M | -64.70%2.31M | -78.56%111.41K | 338.27%8.42M | 355.73%7.91M | 376.54%6.53M | -43.49%519.73K | -97.23%1.92M | -96.91%1.74M | -97.52%1.37M |
| Net deposit increase | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net increase in borrowings from central bank | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net increase in placements from other financial institutions | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash received from interests, fees and commissions | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net increase in repurchase business capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Premiums received from original insurance contracts | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net cash received from reinsurance business | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net increase in deposits from policyholders | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net increase in funds disbursed | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net cash received from trading securities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash received relating to other operating activities | 3.34%240.53M | 53.55%206.68M | 208.76%163.94M | -9.94%317.71M | 6.22%232.75M | -4.40%134.6M | -28.99%53.1M | 13.61%352.78M | -8.63%219.13M | -20.06%140.8M |
| Cash inflows from operating activities | -14.32%7.02B | -5.03%4.81B | 15.11%2.28B | -6.64%13.02B | -18.96%8.19B | -18.74%5.06B | -21.03%1.98B | 12.77%13.94B | 13.45%10.11B | 15.60%6.23B |
| Goods services cash paid | -16.76%4.2B | -21.42%2.67B | -12.70%1.74B | -7.87%6.72B | -1.13%5.05B | 12.92%3.4B | 34.35%1.99B | 4.66%7.29B | 1.99%5.1B | -8.94%3.01B |
| Staff behalf paid | -10.25%1.32B | -8.83%906.46M | -11.56%448.03M | -5.15%1.94B | -5.00%1.47B | -0.77%994.28M | 5.58%506.57M | 3.88%2.05B | 6.05%1.55B | 4.33%1B |
| All taxes paid | 24.64%896.6M | 44.14%679.46M | 31.39%318.25M | 29.04%1.2B | 16.60%719.33M | 40.00%471.4M | 55.78%242.22M | 8.52%929M | -0.25%616.92M | -7.71%336.7M |
| Net loan and advance increase | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net deposit in central bank and institutions | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net lend capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash paid for fees and commissions | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash paid for indemnity of original insurance contract | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Policy dividend cash paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash paid relating to other operating activities | 27.12%1.01B | 31.59%656.49M | 83.23%479.18M | 77.56%1.81B | 10.93%791.42M | 8.15%498.89M | 31.22%261.52M | -15.35%1.02B | -25.72%713.46M | -24.43%461.28M |
| Cash outflows from operating activities | -7.53%7.42B | -8.39%4.91B | -0.58%2.98B | 3.39%11.67B | 0.57%8.03B | 11.51%5.36B | 29.56%3B | 2.62%11.29B | -0.75%7.98B | -8.23%4.81B |
| Net cash flows from operating activities | -347.87%-405.09M | 65.06%-105.07M | 31.07%-702.32M | -49.30%1.35B | -92.31%163.43M | -121.18%-300.68M | -629.15%-1.02B | 94.69%2.65B | 145.36%2.13B | 858.28%1.42B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 147.90%6.36B | 313.99%5.66B | 267.43%3.19B | -20.15%6.11B | -57.02%2.56B | -71.34%1.37B | -59.20%869.48M | -30.67%7.65B | -21.45%5.97B | -5.44%4.77B |
| Cash received from returns on investments | 74.87%20.95M | 59.03%13.16M | 185.39%7.58M | -11.14%20.61M | -37.80%11.98M | -36.56%8.28M | -95.47%2.65M | -86.68%23.19M | -84.49%19.26M | -86.79%13.05M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 461.02%10.19M | 2,855.82%9.54M | 11,555.11%3.9M | 88.36%4.22M | -6.60%1.82M | -65.51%322.71K | -90.18%33.46K | -92.10%2.24M | -92.30%1.95M | -91.48%935.65K |
| Net cash received from disposal of subsidiaries and other business units | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash received relating to other investing activities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash inflows from investing activities | 147.78%6.39B | 313.05%5.68B | 267.61%3.21B | -20.09%6.13B | -56.94%2.58B | -71.24%1.38B | -60.18%872.17M | -31.69%7.67B | -22.69%5.99B | -7.18%4.78B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -55.48%206.66M | -53.04%137.44M | -50.10%77.65M | -20.81%603.16M | -20.63%464.18M | -16.94%292.69M | 16.39%155.63M | -15.20%761.69M | -10.45%584.8M | -10.86%352.38M |
| Cash paid to acquire investments | 60.84%5.49B | 359.06%4.44B | 1,061.80%2.25B | -9.80%7.79B | -48.20%3.41B | -81.61%966.75M | -92.45%193.75M | -22.99%8.64B | -15.73%6.59B | 2.99%5.26B |
| Net cash paid to acquire subsidiaries and other business units | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Impawned loan net increase | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash paid relating to other investing activities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash outflows from investing activities | 46.92%5.7B | 263.29%4.58B | 566.51%2.33B | -10.69%8.39B | -45.96%3.88B | -77.54%1.26B | -87.05%349.38M | -22.42%9.4B | -15.32%7.18B | 2.00%5.61B |
| Net cash flows from investing activities | 152.94%688.69M | 850.34%1.11B | 67.86%877.58M | -31.13%-2.26B | -9.33%-1.3B | 114.16%116.63M | 202.81%522.79M | -95.86%-1.73B | -62.85%-1.19B | -139.52%-823.6M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --0 | --0 | --0 | -99.60%2.45M | --0 | --0 | --0 | 8,337.12%608.06M | --0 | --0 |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --0 | --0 | --0 | --2.45M | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash from borrowing | -5.61%2.38B | -11.09%1.47B | 0.60%784.11M | 4.22%3.24B | 26.90%2.52B | 25.56%1.65B | -12.50%779.45M | 93.05%3.11B | 71.25%1.99B | 49.65%1.31B |
| Cash received relating to other financing activities | -90.26%8.4M | -91.93%6.95M | --0 | --86.22M | --86.22M | --86.22M | --0 | --0 | --0 | --0 |
| Cash inflows from financing activities | -8.41%2.39B | -15.10%1.47B | 0.60%784.11M | -10.45%3.33B | 31.25%2.61B | 32.12%1.74B | -12.50%779.45M | 129.80%3.72B | 70.19%1.99B | 48.43%1.31B |
| Borrowing repayment | 7.96%2.44B | 18.69%2.05B | 20.73%968.94M | 25.41%3.09B | 33.12%2.26B | 165.77%1.73B | 221.83%802.59M | 22.31%2.46B | 33.58%1.7B | -26.00%649.47M |
| Dividend interest payment | 1.99%1B | 2.04%992.54M | 106.38%20.43M | 29.47%987.38M | 32.98%981.46M | 45.03%972.66M | -43.47%9.9M | 13.68%762.61M | 13.20%738.07M | 6.19%670.65M |
| -Including:Cash payments for dividends or profit to minority shareholders | --0 | --0 | --0 | --0 | --0 | --0 | --0 | 0.00%60M | 0.00%60M | --0 |
| Cash payments relating to other financing activities | -81.11%26.3M | -84.86%19.29M | -94.88%5.89M | 144.58%149.77M | 214.50%139.21M | 332.03%127.42M | 715.84%114.99M | 6.33%61.23M | 19.99%44.26M | 15.09%29.49M |
| Cash outflows from financing activities | 2.56%3.47B | 8.29%3.06B | 7.31%995.26M | 28.57%4.23B | 36.31%3.38B | 109.40%2.83B | 230.07%927.47M | 19.86%3.29B | 26.55%2.48B | -12.07%1.35B |
| Net cash flows from financing activities | -39.38%-1.08B | -45.59%-1.59B | -42.64%-211.15M | -310.71%-900.43M | -56.59%-776.14M | -3,009.91%-1.09B | -124.27%-148.03M | 137.94%427.33M | 37.57%-495.66M | 94.60%-35.03M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 1,234.92%1.35M | 536,389.89%1.76M | 1,938.26%748.26K | -122.19%-340.68K | -92.02%101.5K | -99.98%328.17 | -154.76%-40.7K | 68.77%1.53M | 1,310.54%1.27M | 555.82%1.76M |
| Net increase in cash and cash equivalents | 58.35%-796.86M | 54.38%-580.87M | 94.54%-35.14M | -233.96%-1.82B | -533.63%-1.91B | -326.16%-1.27B | -319.13%-644.16M | 310.87%1.36B | 167.04%441.26M | 166.61%563.05M |
| Add:Begin period cash and cash equivalents | -54.31%1.53B | -54.31%1.53B | -54.31%1.53B | 68.19%3.35B | 68.19%3.35B | 68.19%3.35B | 68.19%3.35B | -24.44%1.99B | -24.44%1.99B | -24.44%1.99B |
| End period cash equivalent | -48.92%732.33M | -54.27%948.33M | -44.72%1.49B | -54.31%1.53B | -41.04%1.43B | -18.78%2.07B | 18.34%2.7B | 68.19%3.35B | 23.08%2.43B | 42.76%2.55B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.